- Therapeutic evaluation of sustained-releasing praziquantel (SRP) for clonorchiasis: Phase 1 and 2 clinical studies
-
Choi MH, Chang BC, Lee SJ, Jang IJ, Shin SG, Kho WG, Chun JH, Hong ST
- KMID: 1088768
- Korean J Parasitol.
- 2006 Dec;44(4):361-366.
- doi: 10.3347/kjp.2006.44.4.361
Sustained-releasing praziquantel (SRP) tablet was designed for single dose treatment regimen of clonorchiasis. A previous pre-clinical study confirmed its sustained-releasing characteristics and a better cure rate than conventional praziquantel (PZQ).... -
- CITED
-
- Close
- SHARE
-
- Close
